Vascular hyporesponsiveness to vasopressors in septic shock: From bench to bedside

Intensive Care Medicine

Volumn 36, Issue 12, 2010, Pages 2019-2029

  Levy, B ^a,b   Collin, S ^a   Sennoun, N ^a   Ducrocq, N ^a,b   Kimmoun, A ^a,b   Asfar, P ^c   Perez, P ^a   Meziani, F ^d  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Catecholamine; Nitric oxide; Potassium channels; Septic shock; Vasopressor

Indexed keywords

ACTIN; ACTIVATED PROTEIN C; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALPHA ADRENERGIC RECEPTOR; ARGIPRESSIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLOOXYGENASE 2; DOPAMINE; HYDROCORTISONE; HYDROGEN SULFIDE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NITRIC OXIDE; NITROUS OXIDE; NORADRENALIN; PEROXYNITRITE; PROSTACYCLIN; TERLIPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN;

BLOOD VESSEL REACTIVITY; CORTICOSTEROID THERAPY; CYTOSKELETON; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SELECTIVITY; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INSULIN TREATMENT; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR HYPOREACTIVITY; VASCULAR SMOOTH MUSCLE; VASOPRESSIN BLOOD LEVEL;

EID: 78649316272     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-2045-8     Document Type: Review

References (81)

1. DC Angus WT Linde-Zwirble J Lidicker G Clermont J Carcillo MR Pinsky 2001 Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 1303 1310 1:STN:280:DC%2BD3Mvgs12gtg%3D%3D 10.1097/00003246-200107000-00002 11445675
2. MW Merx C Weber 2007 Sepsis and the heart Circulation 116 793 802 1:STN:280:DC%2BD2svosVSlug%3D%3D 10.1161/CIRCULATIONAHA.106.678359 17698745 (Pubitemid 47255997)
3. N Matsuda Y Hattori 2007 Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction J Smooth Muscle Res 43 117 137 10.1540/jsmr.43.117 17928746
4. JG Umans ME Wylam RW Samsel J Edwards PT Schumacker 1993 Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta Am Rev Respir Dis 148 1638 1645 1:STN:280:DyaK2c%2FnvFWisg%3D%3D 8256913
5. D Annane E Bellissant JM Cavaillon 2005 Septic shock Lancet 365 63 78 1:CAS:528:DC%2BD2MXhvF2gsA%3D%3D 10.1016/S0140-6736(04)17667-8 15639681 (Pubitemid 40082148)
6. G Bernardin C Pradier F Tiger P Deloffre M Mattei 1996 Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock Intensive Care Med 22 17 25 1:STN:280:DyaK2s%2FhtVeksA%3D%3D 10.1007/BF01728326 8857433 (Pubitemid 26042387)
7. O Abid S Akca P Haji-Michael JL Vincent 2000 Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure Crit Care Med 28 947 949 1:STN:280:DC%2BD3c3mslalsw%3D%3D 10.1097/00003246- 200004000-00006 10809264
8. B Lamia D Chemla C Richard JL Teboul 2005 Clinical review: interpretation of arterial pressure wave in shock states Crit Care 9 601 606 10.1186/cc3891 16356245
9. S Benchekroune PC Karpati C Berton C Nathan J Mateo M Chaara F Riche MJ Laisne D Payen A Mebazaa 2008 Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock J Trauma 64 1188 1195 10.1097/TA.0b013e31811f3a45 18469640 (Pubitemid 351671211)
10. CR Benedict JA Rose 1992 Arterial norepinephrine changes in patients with septic shock Circ Shock 38 165 172 1:STN:280:DyaK3s7osFWmuw%3D%3D 1292880
11. DW Landry JA Oliver 2001 The pathogenesis of vasodilatory shock N Engl J Med 345 588 595 1:CAS:528:DC%2BD3MXmsl2gtLw%3D 10.1056/NEJMra002709 11529214 (Pubitemid 32772102)
12. S Alvarez A Boveris 2004 Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia Free Radic Biol Med 37 1472 1478 1:CAS:528: DC%2BD2cXnvFahs74%3D 10.1016/j.freeradbiomed.2004.06.034 15454287 (Pubitemid 39349248)
13. JO Lundberg E Weitzberg 2005 NO generation from nitrite and its role in vascular control Arterioscler Thromb Vasc Biol 25 915 922 1:CAS:528: DC%2BD2MXjsVCjtLw%3D 10.1161/01.ATV.0000161048.72004.c2 15746440 (Pubitemid 40627834)
14. DD Rees JE Monkhouse D Cambridge S Moncada 1998 Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse Br J Pharmacol 124 540 546 1:CAS:528:DyaK1cXjslSis7w%3D 10.1038/sj.bjp.0701815 9647479 (Pubitemid 28254511)
15. G Julou-Schaeffer GA Gray I Fleming C Schott JR Parratt JC Stoclet 1990 Loss of vascular responsiveness induced by endotoxin involves l-arginine pathway Am J Physiol 259 H1038 H1043 1:CAS:528:DyaK3cXmt1yksLY%3D 2221111 (Pubitemid 20352300)
16. WA Boyle 3rd LS Parvathaneni V Bourlier C Sauter VE Laubach JP Cobb 2000 iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice Circ Res 87 E18 E24 1:CAS:528:DC%2BD3MXhslOitro%3D 11009571
17. TA Walker SE Curtis CE King-VanVlack CK Chapler B Vallet SM Cain 1995 Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs Shock 4 415 420 1:STN:280:DyaK287ptlaitg%3D%3D 8608398
18. JL Vincent H Zhang C Szabo JC Preiser 2000 Effects of nitric oxide in septic shock Am J Respir Crit Care Med 161 1781 1785 1:STN:280: DC%2BD3czhtFeqtA%3D%3D 10852744
19. A Lopez JA Lorente J Steingrub J Bakker A McLuckie S Willatts M Brockway A Anzueto L Holzapfel D Breen MS Silverman J Takala J Donaldson C Arneson G Grove S Grossman R Grover 2004 Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock Crit Care Med 32 21 30 1:CAS:528:DC%2BD2cXhtV2mtw%3D%3D 10.1097/01.CCM.0000105581.01815.C6 14707556
20. B Levy M Valtier C de Chillou PE Bollaert D Cane JP Mallie 1999 Beneficial effects of l-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats Shock 11 98 103 1:STN:280:DyaK1M7ltlyltA%3D%3D 10.1097/00024382-199902000-00005 10030795
21. A Cauwels 2007 Nitric oxide in shock Kidney Int 72 557 565 1:CAS:528:DC%2BD2sXpsVartrk%3D 10.1038/sj.ki.5002340 17538569 (Pubitemid 47312788)
22. A Cauwels ES Buys R Thoonen L Geary J Delanghe S Shiva P Brouckaert 2009 Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner J Exp Med 206 2915 2924 1:CAS:528:DC%2BD1MXhs1Wlsb3I 10.1084/jem.20091236 19934018
23. P Wang M Zhou WG Cioffi KI Bland ZF Ba IH Chaudry 2000 Is prostacyclin responsible for producing the hyperdynamic response during early sepsis? Crit Care Med 28 1534 1539 1:STN:280:DC%2BD3c3pt1Glsg%3D%3D 10.1097/00003246- 200005000-00046 10834708 (Pubitemid 30324536)
24. S Schildknecht M Bachschmid A Baumann V Ullrich 2004 COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells FASEB J 18 757 759 1:CAS:528:DC%2BD2cXjtVyrsbc%3D 14977876
25. K Höcherl C Schmidt B Kurt M Bucher 2008 Activation of the PGI(2)/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock Hypertension 52 330 335 10.1161/HYPERTENSIONAHA.108.112029 18606903
26. GR Bernard AP Wheeler JA Russell R Schein WR Summer KP Steinberg WJ Fulkerson PE Wright BW Christman WD Dupont SB Higgins BB Swindell 1997 The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group N Engl J Med 336 912 918 1:CAS:528: DyaK2sXitlKksrY%3D 10.1056/NEJM199703273361303 9070471 (Pubitemid 27137191)
27. P Pacher JS Beckman L Liaudet 2007 Nitric oxide and peroxynitrite in health and disease Physiol Rev 87 315 424 1:CAS:528:DC%2BD2sXitVagsr8%3D 10.1152/physrev.00029.2006 17237348 (Pubitemid 46217686)
28. C Szabo AL Salzman H Ischiropoulos 1995 Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo FEBS Lett 363 235 238 1:CAS:528:DyaK2MXlsFCmsLw%3D 10.1016/0014-5793(95)00322-Z 7537701
29. H Macarthur TC Westfall DP Riley TP Misko D Salvemini 2000 Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock Proc Natl Acad Sci U S A 97 9753 9758 1:CAS:528:DC%2BD3cXmtVentLY%3D 10.1073/pnas.97.17.9753 10944234
30. D Salvemini ZQ Wang JL Zweier A Samouilov H Macarthur TP Misko MG Currie S Cuzzocrea JA Sikorski DP Riley 1999 A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats Science 286 304 306 1:CAS:528:DC%2BD3cXitF2kt7g%3D 10.1126/science.286.5438.304 10514375 (Pubitemid 29484695)
31. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog J Clin Invest 89 2071 2074 1:CAS:528:DyaK38XksVGks74%3D 10.1172/JCI115820 1602014
32. JF Buckley M Singer LH Clapp 2006 Role of KATP channels in sepsis Cardiovasc Res 72 220 230 1:CAS:528:DC%2BD28XhtVygsLjO 10.1016/j.cardiores.2006. 07.011 16963005 (Pubitemid 44511912)
33. S Warrillow M Egi R Bellomo 2006 Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock Crit Care Med 34 980 985 1:CAS:528: DC%2BD28Xis1ersb0%3D 10.1097/01.CCM.0000206114.19707.7C 16484892
34. A Morelli M Lange C Ertmer K Broeking H Van Aken A Orecchioni M Rocco A Bachetoni DL Traber G Landoni P Pietropaoli M Westphal 2007 Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport Shock 28 530 535 1:CAS:528:DC%2BD2sXhtlSqurjK 17589379
35. A Cauwels P Brouckaert 2008 Critical role for small and large conductance calcium-dependent potassium channels in endotoxemia and TNF toxicity Shock 29 577 582 1:CAS:528:DC%2BD1cXmtFyhurk%3D 18467968
36. P Pickkers MJ Dorresteijn MP Bouw JG van der Hoeven P Smits 2006 In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia Circulation 114 414 421 1:CAS:528: DC%2BD28Xnt1agsbY%3D 10.1161/CIRCULATIONAHA.105.590232 16864730 (Pubitemid 44264823)
37. PE Marik SM Pastores D Annane GU Meduri CL Sprung W Arlt D Keh J Briegel A Beishuizen I Dimopoulou S Tsagarakis M Singer GP Chrousos G Zaloga F Bokhari M Vogeser 2008 Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine Crit Care Med 36 1937 1949 1:CAS:528:DC%2BD1cXmsFymsLc%3D 10.1097/CCM. 0b013e31817603ba 18496365
38. D Annane V Maxime F Ibrahim JC Alvarez E Abe P Boudou 2006 Diagnosis of adrenal insufficiency in severe sepsis and septic shock Am J Respir Crit Care Med 174 1319 1326 10.1164/rccm.200509-1369OC 16973979 (Pubitemid 44913033)
39. CL Sprung D Annane D Keh R Moreno M Singer K Freivogel YG Weiss J Benbenishty A Kalenka H Forst PF Laterre K Reinhart BH Cuthbertson D Payen J Briegel 2008 Hydrocortisone therapy for patients with septic shock N Engl J Med 358 111 124 1:CAS:528:DC%2BD1cXltFWltw%3D%3D 10.1056/NEJMoa071366 18184957
40. J Briegel CL Sprung D Annane M Singer D Keh R Moreno P Mohnle Y Weiss A Avidan FM Brunkhorst F Fiedler M Vogeser 2009 Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock Intensive Care Med 35 2151 2156 1:CAS:528:DC%2BD1MXhsVCisbrJ 10.1007/s00134-009-1627-9 19760208
41. LL Wu C Tang MS Liu 1997 Hyper- and hypocardiodynamic states are associated with externalization and internalization, respectively, of alpha-adrenergic receptors in rat heart during sepsis Shock 7 318 323 1:STN:280:DyaK2szgvVCguw%3D%3D 10.1097/00024382-199705000-00002 9165665
42. M McMillan B Chernow BL Roth 1986 Hepatic alpha 1-adrenergic receptor alteration in a rat model of chronic sepsis Circ Shock 19 185 193 1:CAS:528:DyaL28XksVSgsbw%3D 3013454
43. TL Hwang YT Lau SF Huang MF Chen MS Liu 1994 Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis Hepatology 20 638 642 1:STN:280:DyaK2czlslGntQ%3D%3D 10.1002/hep.1840200314 8076922
44. E de Montmollin J Aboab A Mansart D Annane 2009 Bench-to-bedside review: β-adrenergic modulation in sepsis Crit Care 13 230 10.1186/cc8026 19863760
45. ME Pacheco A Beltran J Redondo AM Manso MJ Alonso M Salaices 2006 High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-betaII Eur J Pharmacol 538 115 123 1:CAS:528:DC%2BD28XkvVygur0%3D 10.1016/j.ejphar.2006.03.052 16631733
46. B Ellger MC Richir PA van Leeuwen Y Debaveye L Langouche I Vanhorebeek T Teerlink G Van den Berghe 2008 Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity Endocrinology 149 3148 3157 1:CAS:528:DC%2BD1cXms1enuro%3D 10.1210/en.2007-1558 18292189 (Pubitemid 351724509)
47. JS Holger DJ Dries KW Barringer BJ Peake TJ Flottemesch JJ Marini 2010 Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model Acad Emerg Med 17 429 435 10.1111/j.1553-2712.2010.00695.x 20370783
48. D Annane A Cariou V Maxime E Azoulay G D'Honneur JF Timsit Y Cohen M Wolf M Fartoukh C Adrie C Santre PE Bollaert A Mathonet R Amathieu A Tabah C Clec'h J Mayaux J Lejeune S Chevret 2010 Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial JAMA 303 341 348 10.1001/jama.2010.516 20103758
49. JA Mitchell KL Kohlhaas R Sorrentino TD Warner F Murad JR Vane 1993 Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors Br J Pharmacol 109 265 270 1:CAS:528:DyaK3sXksVejtLw%3D 7684306
50. JC Stoclet MC Martinez P Ohlmann S Chasserot C Schott AL Kleschyov F Schneider R Andriantsitohaina 1999 Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock Circulation 100 107 112 1:CAS:528: DyaK1MXkvV2qtb8%3D 10402437
51. PE Spronk C Ince MJ Gardien KR Mathura HM Oudemans-van Straaten DF Zandstra 2002 Nitroglycerin in septic shock after intravascular volume resuscitation Lancet 360 1395 1396 10.1016/S0140-6736(02)11393-6 12423989 (Pubitemid 35341307)
52. RP Dellinger MM Levy JM Carlet J Bion MM Parker R Jaeschke K Reinhart DC Angus C Brun-Buisson R Beale T Calandra JF Dhainaut H Gerlach M Harvey JJ Marini J Marshall M Ranieri G Ramsay J Sevransky BT Thompson S Townsend JS Vender JL Zimmerman JL Vincent 2008 Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 17 60 10.1007/s00134-007-0934-2 18058085
53. D De Backer P Biston J Devriendt C Madl D Chochrad C Aldecoa A Brasseur P Defrance P Gottignies JL Vincent 2010 Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 779 789 10.1056/NEJMoa0907118 20200382
54. D LeDoux ME Astiz CM Carpati EC Rackow 2000 Effects of perfusion pressure on tissue perfusion in septic shock Crit Care Med 28 2729 2732 1:STN:280:DC%2BD3cvntFKnug%3D%3D 10.1097/00003246-200008000-00007 10966242
55. MJ Breslow B Ligier 1991 Hyperadrenergic states Crit Care Med 19 1566 1579 1:STN:280:DyaK38%2FntVWnsw%3D%3D 10.1097/00003246-199112000-00021 1959378
56. PA Insel 1996 Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors-evolving concepts and clinical implications N Engl J Med 334 580 585 1:CAS:528:DyaK28XhvVCjs78%3D 10.1056/NEJM199602293340907 8569827 (Pubitemid 26066133)
57. S Katsaragakis A Kapralou D Theodorou H Markogiannakis A Larentzakis KM Stamou P Drimousis I Bramis 2006 Refractory septic shock: efficacy and safety of very high doses of norepinephrine Methods Find Exp Clin Pharmacol 28 307 313 1:CAS:528:DC%2BD28XpsVensb4%3D 10.1358/mf.2006.28.5.990203 16845448 (Pubitemid 44047197)
58. M Lange C Ertmer M Westphal 2008 Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis Intensive Care Med 34 821 832 1:CAS:528:DC%2BD1cXovV2rtrY%3D 10.1007/s00134-007-0946-y 18066524 (Pubitemid 351571184)
59. MY Kirov OV Evgenov NV Evgenov EM Egorina MA Sovershaev B Sveinbjornsson EV Nedashkovsky LJ Bjertnaes 2001 Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study Crit Care Med 29 1860 1867 1:CAS:528:DC%2BD3MXotFyitbY%3D 10.1097/00003246-200110000-00002 11588440
60. PM Honore JR Matson 2002 Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with Crit Care Med 30 1673 1674 10.1097/00003246-200207000-00057 12131009
61. K Ataman M Jehmlich S Kock S Neumann M Leischik Z Filipovic HB Hopf 2002 Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock Intensive Care Med 28 1164 1167 10.1007/s00134-002-1375-6 12185443 (Pubitemid 34985245)
62. DW Landry HR Levin EM Gallant RC Ashton Jr S Seo D D'Alessandro MC Oz JA Oliver 1997 Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 95 1122 1125 1:STN:280:DyaK2s3gslGntA%3D%3D 9054839 (Pubitemid 27097820)
63. T Sharshar R Carlier A Blanchard A Feydy F Gray M Paillard JC Raphael P Gajdos D Annane 2002 Depletion of neurohypophyseal content of vasopressin in septic shock Crit Care Med 30 497 500 1:CAS:528:DC%2BD38XislSmsr4%3D 10.1097/00003246-200203000-00001 11990905
64. M Leone WA Boyle 2006 Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions Crit Care Med 34 1126 1130 1:CAS:528:DC%2BD28Xis1ertr0%3D 10.1097/01.CCM.0000206466.56669.BE 16484914
65. JA Russell KR Walley J Singer AC Gordon PC Hebert DJ Cooper CL Holmes S Mehta JT Granton MM Storms DJ Cook JJ Presneill D Ayers 2008 Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 358 877 887 1:CAS:528:DC%2BD1cXisF2hsr4%3D 10.1056/NEJMoa067373 18305265 (Pubitemid 351397087)
66. M Westphal DL Traber 2005 Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med 33 455 457 10.1097/01.CCM.0000153526.24976.83 15699859 (Pubitemid 40216569)
67. K Broking M Lange A Morelli C Ertmer HV Aken M Luecke S Rehberg N Bowering HG Bone DL Traber M Westphal 2008 Employing dobutamine as a useful agent to reverse the terlipressin-linked impairments in cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep Shock 29 71 77 17666952
68. M Lange A Morelli C Ertmer K Broking S Rehberg H Van Aken DL Traber M Westphal 2007 Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications Shock 28 394 400 1:CAS:528:DC%2BD2sXhtFGqtLjP 10.1097/shk.0b013e318050c836 17577137 (Pubitemid 47415248)
69. GR Bernard JL Vincent PF Laterre SP LaRosa JF Dhainaut A Lopez-Rodriguez JS Steingrub GE Garber JD Helterbrand EW Ely CJ Fisher Jr 2001 Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699 709 1:CAS:528:DC%2BD3MXitFamt7s%3D 10.1056/NEJM200103083441001 11236773 (Pubitemid 32204987)
70. LO Mosnier BV Zlokovic JH Griffin 2007 The cytoprotective protein C pathway Blood 109 3161 3172 1:CAS:528:DC%2BD2sXksFWitLg%3D 10.1182/blood-2006- 09-003004 17110453 (Pubitemid 46572500)
71. CT Esmon 2006 The endothelial protein C receptor Curr Opin Hematol 13 382 385 1:CAS:528:DC%2BD28XhtVSrs77J 10.1097/01.moh.0000239712.93662.35 16888445 (Pubitemid 44168461)
72. DE Joyce L Gelbert A Ciaccia B DeHoff BW Grinnell 2001 Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis J Biol Chem 276 11199 11203 1:CAS:528: DC%2BD3MXjvFGjsL0%3D 10.1074/jbc.C100017200 11278252 (Pubitemid 38089304)
73. Bilbault P, Lavaux T, Launoy A, Gaub MP, Meyer N, Oudet P, Pottecher T, Jaeger A, Schneider F (2007) Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients. Crit Care Med 35:69-75
74. S Nacira F Meziani O Dessebe V Cattan S Collin C Montemont S Gibot P Asfar A Ramaroson V Regnault M Slama T Lecompte P Lacolley B Levy 2009 Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress Crit Care Med 37 246 255 1:CAS:528:DC%2BD1cXhsFCnu7jI 10.1097/CCM.0b013e318192fe4f 19112282
75. R Favory S Lancel X Marechal S Tissier R Neviere 2006 Cardiovascular protective role for activated protein C during endotoxemia in rats Intensive Care Med 32 899 905 1:CAS:528:DC%2BD1cXhtVOkur7L 10.1007/s00134-006-0166-x 16601957 (Pubitemid 43781373)
76. X Monnet B Lamia N Anguel C Richard G Bonmarchand JL Teboul 2005 Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients Intensive Care Med 31 1573 1576 1:STN:280:DC%2BD2MngtlWksQ%3D%3D 10.1007/s00134-005-2792-0 16175347 (Pubitemid 41598671)
77. D Annane V Sebille C Charpentier PE Bollaert B Francois JM Korach G Capellier Y Cohen E Azoulay G Troche P Chaumet-Riffaut E Bellissant 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 862 871 1:CAS:528:DC%2BD38Xmt1yitL4%3D 10.1001/jama.288.7.862 12186604
78. H Prigent V Maxime D Annane 2004 Clinical review: corticotherapy in sepsis Crit Care 8 122 129 10.1186/cc2374 15025773 (Pubitemid 38436420)
79. E Kilger F Weis J Briegel L Frey AE Goetz D Reuter A Nagy A Schuetz P Lamm A Knoll K Peter 2003 Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery Crit Care Med 31 1068 1074 1:CAS:528: DC%2BD3sXis12qtrg%3D 10.1097/01.CCM.0000059646.89546.98 12682474 (Pubitemid 36444415)
80. S Gibot F Massin C Alauzet C Montemont A Lozniewski PE Bollaert B Levy 2008 Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats Crit Care Med 36 504 510 1:CAS:528: DC%2BD1cXptlejtA%3D%3D 10.1097/01.CCM.0B013E318161FAF3 18091551 (Pubitemid 351158626)
81. E Rivers B Nguyen S Havstad J Ressler A Muzzin B Knoblich E Peterson M Tomlanovich 2001 Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 1368 1377 1:STN:280:DC%2BD38%2FmsFGjtA%3D%3D 10.1056/NEJMoa010307 11794169